The potential is still there and, in the days, weeks and months ahead, we will likely advance and substantially so. There will be considerable volatility which is common to potential high growth stocks. Let's remember, we are still on the OTC BB where lots of shakes do occur for what may appear to be no apparent reason---other than MMs playing their usual games and, as even Barnhill pointed out, investors taking profits. For me, I like to be on the same side of the table as management and, as long as they're holding on and making what appear to be the right moves, I see no reason to sell.
Remmeber, too, that we have no revenues (royalties) yet so much of the price volatility is predicated on lots of guesses about what our potential income stream will be from the prostate test. And, remember, too, that we do yet know if and when the test will roll out and how quickly it will be adopted and how widely accepted it may become and what it will be priced at---which will determine our royalty flow. Further, we have other tests in "development" and thier timelines cannot be predicted with any certainty at this time either.
And then today's announcement mentioned that Tom Gallagher will pursue non-medical applications for our technology and no one knows how soon, how many, how much. I do believe that this too will happen but I have no idea when...other than saying that I believe it will happen and I'll be happy with this and all the other results.
In the end, truth will out and this stock, like all others, will find its true price level.
News 
Market Data 
Discover 
